Skip to search formSkip to main contentSkip to account menu

varenicline

Known as: 6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine, 7,8,9,10-tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine (2R,3R)-2,3-dihydroxybutqanedioate, Varenicline [Chemical/Ingredient] 
A partial agonist of the nicotinic acetylcholine receptor (nAChR) subtype alpha4beta2. Nicotine stimulation of central alpha4beta2 nAChRs located at… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
AIM To determine the rate ratio of neuropsychiatric hospitalizations in new users of varenicline compared to new users of… 
Review
2009
Review
2009
Objective:Varenicline is a novel antismoking agent that reduces cravings and blocks pleasure of nicotine by serving as a partial… 
Highly Cited
2008
Highly Cited
2008
Varenicline, a partial agonist for a4ss2 nicotinic acetylcholine receptors (nAChRs) and full agonist for a7 nAChRs, has been… 
Highly Cited
2006
Highly Cited
2006
The metabolism and disposition of varenicline (7,8,9,10-tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine), a partial… 
Review
2005
Review
2005
  • 2005
  • Corpus ID: 7146885